Literature DB >> 20372120

Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID.

Lin Chang1, Douglas A Drossman.   

Abstract

Mesh：

Year:  2010        PMID： 20372120     DOI： 10.1038/ajg.2010.49

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  8 in total

1.  Constipation: Linaclotide--a stimulating new drug for chronic constipation.

Authors:  Lucinda A Harris
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07       Impact factor: 46.802

2.  Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice.

Authors:  B M R Spiegel; R Bolus; L A Harris; S Lucak; W D Chey; G Sayuk; E Esrailian; A Lembo; H Karsan; K Tillisch; J Talley; L Chang
Journal:  Aliment Pharmacol Ther       Date:  2010-08-30       Impact factor: 8.171

Review 3.  A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome.

Authors:  Jiyeon Lee; Eun-Hyun Lee; Seung Hei Moon
Journal:  Qual Life Res       Date:  2016-09-29       Impact factor: 4.147

4.  Activation of Peripheral Blood CD4+ T-Cells in IBS is not Associated with Gastrointestinal or Psychological Symptoms.

Authors:  Yasmin Nasser; Carlene Petes; Celine Simmers; Lilian Basso; Christophe Altier; Katrina Gee; Stephen J Vanner
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

Review 5.  Pharmacological treatments for patients with irritable bowel syndrome: An umbrella review of systematic reviews and meta-analyses.

Authors:  Di Qin; Ling Yue; Bin Xue; Min Chen; Tai-Chun Tang; Hui Zheng
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

6.  Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome.

Authors:  Kathryn T Hall; Anthony J Lembo; Irving Kirsch; Dimitrios C Ziogas; Jeffrey Douaiher; Karin B Jensen; Lisa A Conboy; John M Kelley; Efi Kokkotou; Ted J Kaptchuk
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

7.  Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjects.

Authors:  G Chaddock; C Lam; C L Hoad; C Costigan; E F Cox; E Placidi; I Thexton; J Wright; P E Blackshaw; A C Perkins; L Marciani; P A Gowland; R C Spiller
Journal:  Neurogastroenterol Motil       Date:  2013-10-25       Impact factor: 3.598

8.  Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.

Authors:  Dorte Eskesen; Lillian Jespersen; Birgit Michelsen; Peter J Whorwell; Stefan Müller-Lissner; Cathrine M Morberg
Journal:  Br J Nutr       Date:  2015-09-18       Impact factor: 3.718
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.